| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 9, 2026
New low-profile access technology complements Medtronic’s Onyx™ liquid embolic system for navigation and treatment in smaller, more distal neurovascular anatomy
-
Nov 2, 2026
The next-generation TYRX technology is now available in Canada for patients who receive implantable cardiac or neuromodulation devices
-
Oct 31, 2026
Featured clinical science presentation highlights global randomized trial investigating TAVR intervention alongside guideline-directed medical therapy
-
Oct 26, 2026
- Up to 100 scholarships will be awarded globally to students pursuing degrees or credentials in health tech fields.
- Applications open October 26, 2026, and close on January 15, 2027.
-
Oct 7, 2026
Navigated blades will connect powered instrumentation and navigation to offer surgeons greater visibility and flexibility in sinus procedures Oct. 7, 2026 – Medtronic, a global leader in...
-
Oct 6, 2026
At 47th AUGS Annual Scientific Meeting, Medtronic advances AltavivaTM clinical program with 24-month exploratory findings from TITAN 2 showing sustained reductions in nightly nocturia episodes and announces partnership to advance patient awareness of pelvic floor disorders
-
Oct 3, 2026
News comes on heels of recent expanded U.S. payer coverage, reaching 96% of commercially and Medicare insured lives, expanding greater access to care Medtronic, a global leader in healthcare...
-
Sep 30, 2026
Investigational device to be studied in pre-market, randomized pivotal trial
-
Sep 29, 2026
Company recognized for improving healthcare outcomes through technology
-
Sep 16, 2026
A next-generation blade designed to improve efficiency in paranasal sinus surgery
-
Sep 10, 2026
More than 23 procedures performed across seven sites in Germany, the United Kingdom, Italy, and Spain
-
Sep 3, 2026
Following recent U.S. Food and Drug Administration (FDA) labeling approval, European label milestone reinforces Medtronic leadership in advancing aortic care based on clinical evidence supporting the treatment of ruptured abdominal aortic aneurysms (rAAA).
-
Sep 2, 2026
GALWAY, Ireland, September 2, 2026 – Medtronic (NYSE: MDT), a global leader in healthcare technology announced that the Centers for Medicare and Medicaid Services (CMS) has granted a New...
-
Aug 5, 2026
Lower viscosity formulation designed to enable more distal penetration with 1-minute shake time
-
Jun 17, 2026
New, enhanced visualization†, seamless streaming, retrospective recording, and other advanced features to support the clinical need to intubate with first-pass success‡,1,2
-
Jun 8, 2026
Following recent U.S. FDA clearance, Medtronic expands access to its next-generation ENT navigation platform across Europe
-
Jun 4, 2026
The FDA cleared multi-parameter wearable designed for continuous monitoring of vital signs enhances the Acute Care & Monitoring portfolio of patient monitoring solutions.
-
May 28, 2026
SINGAPORE, [May 25, 2026] – Medtronic plc, a global leader in healthcare technology, announced that Medtronic Singapore and the Society of Colorectal Surgeons, Singapore (SCRS) have signed a...


